MOLECULAR CARCINOGENESIS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2024-12-18 ms3000001788822144 来自上海

偏重的研究方向：肿瘤
经验分享：7.18投稿
7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂）
9.10返修（总共给了六十天时间补实验）
10.14修回（第二天系统重新变成under review）
10.31接收

2 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2023-04-06 ms7000001027936853 来自重庆

偏重的研究方向：肿瘤;非编码RNA
经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收

142 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2024-03-28 ms1000001248507298 来自江苏

偏重的研究方向：肿瘤;非编码RNA;分子机制
经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么

73 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2024-05-15 ms7000000138744330 来自江苏省

偏重的研究方向：肿瘤
经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催

86 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2023-02-18 ms9000001393570186 来自重庆

审稿速度:3.0 | 投稿命中率:50.0
经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review）
2023-2-18催稿无反应
-后续更新

95 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2024-05-13 ms8000001259738614 来自黑龙江省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：磨磨蹭蹭

77 0

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2024-04-08 ms5000001127810224 来自浙江省

审稿速度:6.0
偏重的研究方向：肿瘤
经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。

91 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2024-04-18 lijiwei.li_99476115 来自河南省

大神们，这个杂志需要原始数据吗

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2023-03-28 ms7000000699329508 来自广东省

想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2243416, encodeId=79f422434169f, content=偏重的研究方向：肿瘤 经验分享：7.18投稿 7.19 under review（漫长的等待，一个多月没动静，后面鼓起勇气发了封邮件询问了一下，也没收到回复😂） 9.10返修（总共给了六十天时间补实验） 10.14修回（第二天系统重新变成under review） 10.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822144, createdTime=Wed Dec 18 23:43:56 CST 2024, time=2024-12-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124175, encodeId=691f21241e53a, content=偏重的研究方向：肿瘤;非编码RNA 经验分享：22.12.19投稿后第二天under review，等了一个月左右的时候发过一篇邮件询问外审时间，23.2.10返修给了六十天时间补实验，23.3.14修回第二天系统重新变成under review，23.3.31接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c9f8340253, createdName=ms7000001027936853, createdTime=Thu Apr 06 21:29:23 CST 2023, time=2023-04-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195879, encodeId=e5d321958e953, content=偏重的研究方向：肿瘤;非编码RNA;分子机制 经验分享：三修了，三修回去又外审1个月了，关键第三次审稿就只是两个描述性问题，不知道在磨叽什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23548208211, createdName=ms1000001248507298, createdTime=Thu Mar 28 16:22:19 CST 2024, time=2024-03-28, status=1, ipAttribution=江苏), GetPortalCommentsPageByObjectIdResponse(id=2204855, encodeId=cdbd22048553c, content=偏重的研究方向：肿瘤 经验分享：投稿一个多月了，从第二天就是under review状态，一直没有变动，也不确定是不是送外审了，着急又不敢催, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Wed May 15 17:00:51 CST 2024, time=2024-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2115258, encodeId=2dea2115258bb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-1-18投稿，第二天就显示review（官方解释是submitted to the editorial office for review） 2023-2-18催稿无反应 -后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46368166920, createdName=ms9000001393570186, createdTime=Sat Feb 18 13:32:36 CST 2023, time=2023-02-18, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2204452, encodeId=70d02204452d8, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：磨磨蹭蹭 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32906491318, createdName=ms8000001259738614, createdTime=Mon May 13 15:33:02 CST 2024, time=2024-05-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2197446, encodeId=2cfb219e44664, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：2023.12.23投稿，2024.2.5返修，四个问题。2024.3.18修回，到现在还没消息.。。。。。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Mon Apr 08 19:56:49 CST 2024, time=2024-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199139, encodeId=7964219913931, content=大神们，这个杂志需要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c8f52561933, createdName=lijiwei.li_99476115, createdTime=Thu Apr 18 16:29:33 CST 2024, time=2024-04-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2122292, encodeId=3473212229232, content=想咨询一个问题，为什么这个杂志投稿的时候，总是退回来提交不成功，说我的文稿要转成PDF格式，可是稿件不就是要求WORD文档吗，我转成PDF也传不上去啊，有没有友友遇到我这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5506976, createdName=ms7000000699329508, createdTime=Tue Mar 28 18:19:49 CST 2023, time=2023-03-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2118015, encodeId=a84b2118015aa, content=二审三个月催稿不回醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b068097115, createdName=ms7000000359211492, createdTime=Mon Mar 06 22:45:51 CST 2023, time=2023-03-06, status=1, ipAttribution=浙江省)]

2023-03-06 ms7000000359211492 来自浙江省

二审三个月催稿不回醉了

120 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务